Surmodics (NASDAQ:SRDX – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a report released on Wednesday.
Separately, Needham & Company LLC reaffirmed a “buy” rating and issued a $47.00 price objective on shares of Surmodics in a research note on Wednesday, April 10th.
View Our Latest Stock Analysis on SRDX
Surmodics Stock Up 0.4 %
Institutional Investors Weigh In On Surmodics
Hedge funds and other institutional investors have recently bought and sold shares of the business. SG Americas Securities LLC purchased a new stake in Surmodics during the 4th quarter worth approximately $163,000. Hillsdale Investment Management Inc. increased its holdings in Surmodics by 15.7% during the 4th quarter. Hillsdale Investment Management Inc. now owns 4,570 shares of the company’s stock worth $166,000 after purchasing an additional 620 shares during the last quarter. Mesirow Financial Investment Management Inc. purchased a new stake in Surmodics during the 1st quarter worth approximately $223,000. Strs Ohio increased its holdings in Surmodics by 97.2% during the 4th quarter. Strs Ohio now owns 7,100 shares of the company’s stock worth $258,000 after purchasing an additional 3,500 shares during the last quarter. Finally, Summit Global Investments purchased a new stake in Surmodics during the 4th quarter worth approximately $360,000. 96.63% of the stock is currently owned by hedge funds and other institutional investors.
About Surmodics
Surmodics, Inc, together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD).
See Also
- Five stocks we like better than Surmodics
- Airline Stocks – Top Airline Stocks to Buy Now
- Hasbro’s Management Made All the Right Calls This Quarter
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- The How and Why of Investing in Gold Stocks
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for Surmodics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surmodics and related companies with MarketBeat.com's FREE daily email newsletter.